Elahere 100 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCR4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,083
Award facts
- Contract value 100% obligated
- $50,082.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,082.72 to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Elahere (mirvetuximab soravtansine) 100 mg/20 mL vials. This contract utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating competitive award through open competition. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 17, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems, particularly the Defense Health Agency, U.S. Coast Guard, and military medical supply chains. The company maintains an extensive portfolio of federal pharmaceutical contracts covering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products to support military healthcare programs worldwide. The Defense Logistics Agency is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, demonstrating continued reliance on established contractors like AmerisourceBergen to meet military medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCR4E?
SPE2DR26FCR4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FCR4E worth?
The government has obligated $50,083 on SPE2DR26FCR4E.
Is contract SPE2DR26FCR4E an order under another contract?
Yes. SPE2DR26FCR4E is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCR4E competed?
The extent of competition for SPE2DR26FCR4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award